Company Name, Ticker, Customers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
CERE's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Cerevel Therapeutics Holdings Inc News
Cerevel Therapeutics Holdings Inc's Free Cash Flow Margin
Cerevel Therapeutics Holdings Inc's Receivables Turnover Ratio
Cerevel Therapeutics Holdings Inc Business Description
Cerevel Therapeutics Holdings Inc Executive Officers
Economic Indicators
Fundamentals
Cerevel Therapeutics Holdings Inc Growth Rates
Cerevel Therapeutics Holdings Inc Profitability
Cerevel Therapeutics Holdings Inc Valuation
Cerevel Therapeutics Holdings Inc Management Effectiveness
Cerevel Therapeutics Holdings Inc Financial Strength
Cerevel Therapeutics Holdings Inc Efficiency
Cerevel Therapeutics Holdings Inc Dividend
Financials
Cerevel Therapeutics Holdings Inc Business Segments
Cerevel Therapeutics Holdings Inc Income Statement
Cerevel Therapeutics Holdings Inc Balance Sheets
Cerevel Therapeutics Holdings Inc Cash Flow Statement
Cerevel Therapeutics Holdings Inc Geographic Information
Suppliers
Cerevel Therapeutics Holdings Inc Suppliers Performance
CERE Suppliers Stock Performance
CERE Suppliers Growth Rates
CERE Suppliers Data
CERE Suppliers Efficiency
CERE Suppliers Management Effectiveness
CERE Suppliers Valuation
CERE Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Cerevel Therapeutics Holdings Inc Market Share
Cerevel Therapeutics Holdings Inc Competition Performance
Cerevel Therapeutics Holdings Inc Competitors Results
CERE Competitors Stock Performance
CERE Competitors Growth Rates
CERE Workforce Efficiency at the Competitors
CERE Competitors Efficiency
CERE Competitors Management Effectiveness
CERE Competitors Valuation
Customers & Markets
Cerevel Therapeutics Holdings Inc Customers Demand
CERE Customers Expenditure Growth Rates
CERE Customers Performance
CERE Customers Stock Performance
CERE Customers Growth Rates
CERE Workforce Efficiency at the Customers
CERE Customers Efficiency
CERE Customers Management Effectiveness
CERE Customers Valuation
CERE Customers by Companys' Segments
Charts & Quotes
Cerevel Therapeutics Holdings Inc Comparison Charts
CERE OHLC Charts
CERE's Tehnical Upper Indicators
CERE's Tehnical Lower Indicators
CERE's Weekly Charts
CERE's Monthly Charts
Cerevel Therapeutics Holdings Inc's Profile
Company Charts and Quotes
Cerevel Therapeutics Holdings Inc News
Cerevel Therapeutics Holdings Inc's Business Segments
Cerevel Therapeutics Holdings Inc's Income Statement
Cerevel Therapeutics Holdings Inc's Balance Sheets
Cerevel Therapeutics Holdings Inc's Cash Flow Statement
Cerevel Therapeutics Holdings Inc's Profitability
Cerevel Therapeutics Holdings Inc's Financials
CERE's Debt to Equity
Cerevel Therapeutics Holdings Inc's Suppliers
Cerevel Therapeutics Holdings Inc's Competitors
Cerevel Therapeutics Holdings Inc's Markets & Customers
Cerevel Therapeutics Holdings Inc's Market Share
CERE's Suppliers Management Effectiveness
CERE's Competitors Growth Rates
CERE's Charts Upper Indicators
Cerevel Therapeutics Holdings Inc's Customers Expenditure Growth Rates
Economic Indicators
Revenue per Employee by Industry
Profitability Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
Economic Indicators
News
Economy News
Stock News
Energy Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Cerevel Therapeutics Holdings Inc
(
CERE
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Cerevel Therapeutics Holdings Inc 's Yearly Income from Continued Operations Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
CERE Annual Income from Cont. Operations Growth
2022
2021
2020
2015
2014
Y / Y Annual Income from Cont. Operations Change
-
-
-
-
-
Annual Income from Cont. Operations (in millions $)
$-351.51
$-225.33
$-144.40
$-28.16
$-29.32
CERE Company Profile
>>
Back to CERE Fundamentals at a Glance
>>
Back to CERE Growth Comparisons
Annual Income from Cont. Operations Growth Comment
Cerevel Therapeutics Holdings Inc
realized loss from Cont. Operations.
Cerevel Therapeutics Holdings Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2022 Annual Income from Cont. Operations within Healthcare Sector
Y/Y Income from Continued Operations Growth %
2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd
-99.39 %
$ 88.131 millions
Koninklijke Philips Nv